Steven Cohen's position in Dexcom is currently worth $135 Million. That's 0.41% of their equity portfolio (57th largest holding). The first Dexcom trade was made in Q4 2015. Since then Steven Cohen bought shares 23 more times and sold shares on 22 occasions. The stake costed the investor $119 Million, netting the investor a gain of 14% so far.